Yang, Cynthia http://orcid.org/0000-0001-6769-3153
Fridgeirsson, Egill A.
Kors, Jan A.
Reps, Jenna M.
Rijnbeek, Peter R.
Funding for this research was provided by:
Innovative Medicines Initiative 2 Joint Undertaking (806968)
Article History
Received: 27 January 2023
Accepted: 14 December 2023
First Online: 3 January 2024
Declarations
:
: All patient data included in this study were deidentified. The New England Institutional Review Board (IRB) determined that studies conducted in these data are exempt from study-specific IRB review, as these studies do not qualify as human subjects research. No experiments were conducted on humans in this study. The research methods were conducted in accordance with appropriate guidelines.
: Not applicable.
: JMR is an employee of Janssen Research and Development and shareholder of Johnson and Johnson. CY, EAF, JAK and PRR work for a research group who received unconditional research grants from Janssen Research and Development, none of which relate to the content of this work.